Investigational Site Number 124002

Montreal H3T 1E2

0 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Neoplasm, Prostate Cancer Metastatic

Studies at this site

• Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia — Completed
• Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide — Stopped early